Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- Check7 days agoChange DetectedThe page's revision stamp has been updated from v3.6.0 to v3.6.2. This reflects a minor backend/content refresh and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study page now indicates that recruitment has ended ('No longer looking for participants'), clarifying enrollment status. There are also minor UI/content updates, including labeling changes to Intervention/Treatment and the addition of guidance/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor platform update.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.5.4 replaces Revision: v3.5.3. This update changes the page's version label to a newer revision without altering the main content or user-facing features.SummaryDifference0.0%

- Check71 days agoChange DetectedThe Manatí, Puerto Rico site entry was updated to a different spelling (“Manati” without the accent). The page footer/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3”.SummaryDifference0.1%

- Check79 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.